Product Information
TOPIRAMATE 200 MG TABLET is a generic product labeled by Sun Pharmaceutical Industries Inc., priced at $0.1052 per EA under NDC 47335071213. Its NADAC has been published 550 times since Aug 12, 2015.
FDA first approved this application on Mar 27, 2009. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
200 mg/1
Manufacturer
Sun Pharmaceutical Industries Inc.NDC
47335071213
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
2/18/2026
Active Ingredients
TOPIRAMATEApproval Type
Generic (ANDA)
FDA Application
ANDA090278FDA Approved
3/27/2009
TE Code
AB
On Market Since
12/15/2014
Pharmacological Classes
Price Statistics
The NADAC for TOPIRAMATE 200 MG TABLET has been published 550 times since Aug 12, 2015, and over the history we have for it it has declined 22.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1052 per EA |
|---|---|
| All-time high | $0.1348 (Aug 12, 2015) |
| All-time low | $0.0880 (Apr 17, 2024) |
| 52-week high | $0.1092 |
| 52-week low | $0.1009 |
| Median price | $0.1106 |
| Average price | $0.1110 |
| Largest weekly change | -19.3% (Apr 17, 2024) |
| Weeks tracked | 550 |
| Tracking since | Aug 12, 2015 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
+4.0%
3Y
-3.2%
5Y
-10.1%
All
-22.0%
Last surveyed Feb 18, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 16% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TOPIRAMATE 200 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TOPIRAMATE 200 MG TABLET, manufactured by Sun Pharmaceutical Industries Inc., is $0.1052 per EA (NDC 47335071213), effective Feb 18, 2026.
How has the price of TOPIRAMATE 200 MG TABLET changed over time?
Over the history we have for it, the NADAC for TOPIRAMATE 200 MG TABLET has declined 22.0%. It has been tracked across 550 weekly CMS publications since Aug 12, 2015.
What are the highest and lowest recorded NADAC prices for TOPIRAMATE 200 MG TABLET?
Since Aug 12, 2015, the NADAC for TOPIRAMATE 200 MG TABLET has ranged from a low of $0.0880 (Apr 17, 2024) to a high of $0.1348 (Aug 12, 2015), with a median of $0.1106 per EA.
Are there cheaper alternatives to TOPIRAMATE 200 MG TABLET?
Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TOPIRAMATE 200 MG TABLET, is $0.0880 per EA — about 16% below TOPIRAMATE 200 MG TABLET.
Who manufactures TOPIRAMATE 200 MG TABLET?
TOPIRAMATE 200 MG TABLET (NDC 47335071213) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a generic product.